Annovis Bio Ownership 2024 | Who Owns Annovis Bio Now?
Institutional Ownership
9.26%
Insider Ownership
21.56%
Retail Ownership
69.17%
Institutional Holders
49.00
Annovis Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
LMR PARTNERS LLP | 5.38% | 0.03% | 572,100 | -259,300 | -31.19% | 3,295,296 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.40% | - | 361,354 | 3,412 | 0.95% | 2,081,399 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 1.51% | 0.02% | 160,300 | 93,100 | 138.54% | 923,328 | Jun 30, 2024 |
ALTIUM CAPITAL MANAGEMENT LP | 1.46% | 0.36% | 155,300 | 155,300 | 100.00% | 894,528 | Jun 30, 2024 |
CAPTION MANAGEMENT, LLC | 1.18% | 0.01% | 125,000 | -31,500 | -20.13% | 720,000 | Jun 30, 2024 |
BLACKROCK INC. | 0.95% | - | 100,709 | 3,080 | 3.15% | 580,083 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.94% | 0.00% | 100,000 | -150,000 | -60.00% | 576,000 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.72% | - | 76,233 | 5,442 | 7.69% | 439,199 | Jun 30, 2024 |
TORNO CAPITAL, LLC | 0.49% | 0.01% | 52,500 | 52,500 | 100.00% | 302,400 | Jun 30, 2024 |
WESCOTT FINANCIAL ADVISORY GROUP, LLC | 0.39% | 0.03% | 41,607 | - | - | 239,656 | Jun 30, 2024 |
GTS SECURITIES LLC | 0.38% | 0.00% | 40,200 | -28,300 | -41.31% | 231,552 | Jun 30, 2024 |
HAP TRADING, LLC | 0.38% | 0.00% | 40,000 | -14,100 | -26.06% | 15,000 | Jun 30, 2024 |
STERLING INVESTMENT ADVISORS, LTD. | 0.32% | 0.05% | 33,474 | -900 | -2.62% | 192,810 | Jun 30, 2024 |
MODERA WEALTH MANAGEMENT, LLC | 0.29% | 0.00% | 30,513 | - | - | 175,755 | Jun 30, 2024 |
STATE STREET CORP | 0.27% | - | 29,135 | - | - | 167,818,000 | Jun 30, 2024 |
UBS GROUP AG | 0.24% | - | 25,000 | 25,000 | 100.00% | 144,000 | Jun 30, 2024 |
SQUAREPOINT OPS LLC | 0.24% | 0.00% | 25,000 | - | - | 144,000 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 22,100 | -11,500 | -34.23% | 127,296 | Jun 30, 2024 |
MERIT FINANCIAL GROUP, LLC | 0.20% | 0.00% | 21,700 | -500 | -2.25% | 124,992 | Jun 30, 2024 |
XTX TOPCO LTD | 0.19% | 0.01% | 19,907 | 19,907 | 100.00% | 114,664 | Jun 30, 2024 |
Annovis Bio's largest institutional shareholder is LMR PARTNERS LLP, holding 5.38% of the company's total share outstanding, currently valued at $3.30M. The top 10 institutional shareholders own together 16.42% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IKARIAN CAPITAL, LLC | 0.05% | 0.55% | 5,517 | -246,383 | -97.81% | 3,177,792 | Jun 30, 2024 |
ALTIUM CAPITAL MANAGEMENT LP | 1.46% | 0.36% | 155,300 | 155,300 | 100.00% | 894,528 | Jun 30, 2024 |
STERLING INVESTMENT ADVISORS, LTD. | 0.32% | 0.05% | 33,474 | -900 | -2.62% | 192,810 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.00% | 0.05% | 517 | -249,483 | -99.79% | 297,792 | Jun 30, 2024 |
LOKKEN INVESTMENT GROUP LLC | 0.12% | 0.03% | 12,235 | - | - | 70,474 | Jun 30, 2024 |
WESCOTT FINANCIAL ADVISORY GROUP, LLC | 0.39% | 0.03% | 41,607 | - | - | 239,656 | Jun 30, 2024 |
LMR PARTNERS LLP | 5.38% | 0.03% | 572,100 | -259,300 | -31.19% | 3,295,296 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 1.51% | 0.02% | 160,300 | 93,100 | 138.54% | 923,328 | Jun 30, 2024 |
TORNO CAPITAL, LLC | 0.49% | 0.01% | 52,500 | 52,500 | 100.00% | 302,400 | Jun 30, 2024 |
CAPTION MANAGEMENT, LLC | 1.18% | 0.01% | 125,000 | -31,500 | -20.13% | 720,000 | Jun 30, 2024 |
XTX TOPCO LTD | 0.19% | 0.01% | 19,907 | 19,907 | 100.00% | 114,664 | Jun 30, 2024 |
GREENWICH WEALTH MANAGEMENT LLC | 0.14% | 0.01% | 15,075 | 2,500 | 19.88% | 87,000 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 22,100 | -11,500 | -34.23% | 127,296 | Jun 30, 2024 |
MERIT FINANCIAL GROUP, LLC | 0.20% | 0.00% | 21,700 | -500 | -2.25% | 124,992 | Jun 30, 2024 |
MODERA WEALTH MANAGEMENT, LLC | 0.29% | 0.00% | 30,513 | - | - | 175,755 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.13% | 0.00% | 13,600 | -53,100 | -79.61% | 78,336 | Jun 30, 2024 |
OPAL WEALTH ADVISORS, LLC | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 5,760 | Jun 30, 2024 |
SPEARS ABACUS ADVISORS LLC | 0.14% | 0.00% | 15,000 | - | - | 86,400 | Jun 30, 2024 |
HAP TRADING, LLC | 0.38% | 0.00% | 40,000 | -14,100 | -26.06% | 15,000 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.94% | 0.00% | 100,000 | -150,000 | -60.00% | 576,000 | Jun 30, 2024 |
The largest Annovis Bio shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 5.52K shares of Annovis Bio (ANVS), representing 0.55% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ALTIUM CAPITAL MANAGEMENT LP | 1.46% | 0.36% | 155,300 | 155,300 | 100.00% | 894,528 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 1.51% | 0.02% | 160,300 | 93,100 | 138.54% | 923,328 | Jun 30, 2024 |
TORNO CAPITAL, LLC | 0.49% | 0.01% | 52,500 | 52,500 | 100.00% | 302,400 | Jun 30, 2024 |
UBS GROUP AG | 0.24% | - | 25,000 | 25,000 | 100.00% | 144,000 | Jun 30, 2024 |
XTX TOPCO LTD | 0.19% | 0.01% | 19,907 | 19,907 | 100.00% | 114,664 | Jun 30, 2024 |
UBS GROUP AG | 0.12% | - | 12,990 | 12,390 | 2065.00% | 74,822 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.72% | - | 76,233 | 5,442 | 7.69% | 439,199 | Jun 30, 2024 |
BELVEDERE TRADING LLC | 0.04% | - | 4,778 | 4,778 | 100.00% | 27,521 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.40% | - | 361,354 | 3,412 | 0.95% | 2,081,399 | Jun 30, 2024 |
BLACKROCK INC. | 0.95% | - | 100,709 | 3,080 | 3.15% | 580,083 | Jun 30, 2024 |
GREENWICH WEALTH MANAGEMENT LLC | 0.14% | 0.01% | 15,075 | 2,500 | 19.88% | 87,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.06% | 0.00% | 6,858 | 2,060 | 42.93% | 39,502 | Jun 30, 2024 |
OPAL WEALTH ADVISORS, LLC | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 5,760 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 200 | 200 | 100.00% | 1,152 | Jun 30, 2024 |
EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | 0.00% | 83 | 83 | 100.00% | 773 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 1,275 | 75 | 6.25% | 7,344 | Jun 30, 2024 |
STATE STREET CORP | 0.27% | - | 29,135 | - | - | 167,818,000 | Jun 30, 2024 |
BANK OF NEW YORK MELLON CORP | 0.18% | - | 19,059 | - | - | 109,781 | Jun 30, 2024 |
SQUAREPOINT OPS LLC | 0.24% | 0.00% | 25,000 | - | - | 144,000 | Jun 30, 2024 |
WR WEALTH PLANNERS, LLC | 0.00% | 0.00% | 150 | - | - | 864 | Jun 30, 2024 |
As of Jun 30 2024, Annovis Bio's largest institutional buyer is ALTIUM CAPITAL MANAGEMENT LP. The company purchased 155.30K stocks of ANVS, valued at $894.53K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
LMR PARTNERS LLP | 5.38% | 0.03% | 572,100 | -259,300 | -31.19% | 3,295,296 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.00% | 0.05% | 517 | -249,483 | -99.79% | 297,792 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.05% | 0.55% | 5,517 | -246,383 | -97.81% | 3,177,792 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.94% | 0.00% | 100,000 | -150,000 | -60.00% | 576,000 | Jun 30, 2024 |
AFFINITY ASSET ADVISORS, LLC | - | - | - | -72,900 | -100.00% | - | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.13% | 0.00% | 13,600 | -53,100 | -79.61% | 78,336 | Jun 30, 2024 |
BELVEDERE TRADING LLC | 0.04% | - | 4,500 | -38,800 | -89.61% | 25,920 | Jun 30, 2024 |
REDMOND ASSET MANAGEMENT, LLC | - | - | - | -36,157 | -100.00% | - | Jun 30, 2024 |
GTS SECURITIES LLC | 0.11% | 0.00% | 11,300 | -32,700 | -74.32% | 65,088 | Jun 30, 2024 |
CAPTION MANAGEMENT, LLC | 1.18% | 0.01% | 125,000 | -31,500 | -20.13% | 720,000 | Jun 30, 2024 |
GTS SECURITIES LLC | 0.38% | 0.00% | 40,200 | -28,300 | -41.31% | 231,552 | Jun 30, 2024 |
BELVEDERE TRADING LLC | 0.14% | 0.00% | 14,900 | -15,600 | -51.15% | 85,824 | Jun 30, 2024 |
HAP TRADING, LLC | 0.38% | 0.00% | 40,000 | -14,100 | -26.06% | 15,000 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 22,100 | -11,500 | -34.23% | 127,296 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.18% | - | 19,235 | -5,032 | -20.74% | 110,793,000 | Jun 30, 2024 |
QUEST PARTNERS LLC | - | - | - | -3,340 | -100.00% | - | Jun 30, 2024 |
MORGAN STANLEY | 0.05% | - | 5,498 | -1,658 | -23.17% | 31,668 | Jun 30, 2024 |
STERLING INVESTMENT ADVISORS, LTD. | 0.32% | 0.05% | 33,474 | -900 | -2.62% | 192,810 | Jun 30, 2024 |
MERIT FINANCIAL GROUP, LLC | 0.20% | 0.00% | 21,700 | -500 | -2.25% | 124,992 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.05% | - | 5,065 | -449 | -8.14% | 29,174 | Jun 30, 2024 |
As of Jun 30 2024, Annovis Bio's biggest institutional seller is LMR PARTNERS LLP. The company sold -0.26M shares of ANVS, valued at $3.30M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ALTIUM CAPITAL MANAGEMENT LP | 1.46% | 0.36% | 155,300 | 155,300 | 100.00% | 894,528 | Jun 30, 2024 |
TORNO CAPITAL, LLC | 0.49% | 0.01% | 52,500 | 52,500 | 100.00% | 302,400 | Jun 30, 2024 |
UBS GROUP AG | 0.24% | - | 25,000 | 25,000 | 100.00% | 144,000 | Jun 30, 2024 |
XTX TOPCO LTD | 0.19% | 0.01% | 19,907 | 19,907 | 100.00% | 114,664 | Jun 30, 2024 |
BELVEDERE TRADING LLC | 0.04% | - | 4,778 | 4,778 | 100.00% | 27,521 | Jun 30, 2024 |
OPAL WEALTH ADVISORS, LLC | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 5,760 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 200 | 200 | 100.00% | 1,152 | Jun 30, 2024 |
EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | 0.00% | 83 | 83 | 100.00% | 773 | Jun 30, 2024 |
Annovis Bio's largest new institutional shareholder by number of shares is ALTIUM CAPITAL MANAGEMENT LP, purchased 155.30K shares, valued at $894.53K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AFFINITY ASSET ADVISORS, LLC | - | - | - | -72,900 | -100.00% | - | Jun 30, 2024 |
REDMOND ASSET MANAGEMENT, LLC | - | - | - | -36,157 | -100.00% | - | Jun 30, 2024 |
QUEST PARTNERS LLC | - | - | - | -3,340 | -100.00% | - | Jun 30, 2024 |
FNY INVESTMENT ADVISERS, LLC | - | - | - | -400 | -100.00% | - | Jun 30, 2024 |
YHB INVESTMENT ADVISORS, INC. | - | - | - | -85 | -100.00% | - | Jun 30, 2024 |
Annovis Bio's largest sold out institutional shareholder by shares sold is AFFINITY ASSET ADVISORS, LLC, sold -72.90K shares, valued at -, as of undefined.
Annovis Bio Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
BRIDGEWAY FUNDS INC | 0.01% | 32,500 | 10,000 | 44.44% | Mar 28, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.01% | 4,100 | - | - | Mar 31, 2024 |
BNY Mellon Strategic Funds, Inc. | 0.01% | 15,506 | - | - | Mar 31, 2024 |
ETFis Series Trust I | 0.00% | 2,387 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 340,805 | -85,524 | -20.06% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 62,848 | 15,533 | 32.83% | Feb 29, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 4,800 | - | - | Mar 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 4,518 | - | - | Mar 31, 2024 |
Principal Exchange-Traded Funds | 0.00% | 913 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 2,061 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 9,714 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 8,428 | - | - | Jan 31, 2024 |
SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 22,331 | - | - | Dec 31, 2023 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 776 | 776 | - | Jan 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 693 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 15,863 | 1,744 | 12.35% | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,091 | - | - | Mar 31, 2024 |
SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 15,244 | - | - | Feb 29, 2024 |
Annovis Bio's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 32.50K shares, compromising 0.01% of its total assets.
Annovis Bio Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 49 | -3.92% |
31 Mar, 24 | 51 | 15.91% |
31 Dec, 23 | 44 | 51.72% |
30 Sep, 23 | 29 | 3.57% |
30 Jun, 23 | 28 | 27.27% |
31 Mar, 23 | 22 | - |
31 Dec, 22 | 22 | - |
30 Sep, 22 | 22 | -8.33% |
30 Jun, 22 | 24 | 4.35% |
31 Mar, 22 | 23 | -20.69% |
31 Dec, 21 | 29 | -19.44% |
30 Sep, 21 | 36 | -35.71% |
30 Jun, 21 | 56 | 86.67% |
31 Mar, 21 | 30 | 150.00% |
31 Dec, 20 | 12 | 9.09% |
30 Sep, 20 | 11 | 37.50% |
30 Jun, 20 | 8 | 14.29% |
31 Mar, 20 | 7 | - |
31 Mar, 12 | 1 | - |
As of 30 Jun 24, 49 institutions are holding Annovis Bio's shares, representing a decrease of -3.92% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 984,303 | -19.54% |
31 Mar, 24 | 1,223,331 | 1.56% |
31 Dec, 23 | 1,204,492 | 8.33% |
30 Sep, 23 | 1,111,900 | -13.05% |
30 Jun, 23 | 1,278,741 | 70.00% |
31 Mar, 23 | 752,202 | 1.52% |
31 Dec, 22 | 740,907 | 0.43% |
30 Sep, 22 | 737,704 | -4.25% |
30 Jun, 22 | 770,423 | -13.39% |
31 Mar, 22 | 889,559 | -20.29% |
31 Dec, 21 | 1,116,019 | -2.16% |
30 Sep, 21 | 1,140,634 | -10.12% |
30 Jun, 21 | 1,269,043 | 52.09% |
31 Mar, 21 | 834,414 | 9.80% |
31 Dec, 20 | 759,911 | 140.82% |
30 Sep, 20 | 315,551 | 29.41% |
30 Jun, 20 | 243,843 | 26.22% |
31 Mar, 20 | 193,186 | - |
31 Mar, 12 | 17,411 | - |
Annovis Bio (ANVS) has 984.30K shares outstanding as of 30 Jun 24, down -19.54% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 9.26% | 6.99% |
31 Mar, 24 | 11.51% | 7.20% |
31 Dec, 23 | 12.64% | 8.31% |
30 Sep, 23 | 12.34% | 6.05% |
30 Jun, 23 | 14.29% | 16.96% |
31 Mar, 23 | 9.18% | 11.14% |
31 Dec, 22 | 9.08% | 11.11% |
30 Sep, 22 | 9.04% | 10.15% |
30 Jun, 22 | 9.44% | 7.94% |
31 Mar, 22 | 10.90% | 5.09% |
31 Dec, 21 | 14.63% | 7.38% |
30 Sep, 21 | 14.08% | 4.75% |
30 Jun, 21 | 17.23% | 11.85% |
31 Mar, 21 | 12.06% | 8.31% |
31 Dec, 20 | 12.04% | 57.12% |
30 Sep, 20 | 4.59% | 36.36% |
30 Jun, 20 | 3.55% | 20.15% |
31 Mar, 20 | 4.20% | - |
31 Mar, 12 | 0.40% | - |
As of 30 Jun 24, Annovis Bio is held by 9.26% institutional shareholders, representing a 6.99% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 17 | -41.38% |
31 Mar, 24 | 29 | 16.00% |
31 Dec, 23 | 25 | 177.78% |
30 Sep, 23 | 9 | -25.00% |
30 Jun, 23 | 12 | 9.09% |
31 Mar, 23 | 11 | 37.50% |
31 Dec, 22 | 8 | - |
30 Sep, 22 | 8 | - |
30 Jun, 22 | 8 | -20.00% |
31 Mar, 22 | 10 | -23.08% |
31 Dec, 21 | 13 | -38.10% |
30 Sep, 21 | 21 | -50.00% |
30 Jun, 21 | 42 | 100.00% |
31 Mar, 21 | 21 | 320.00% |
31 Dec, 20 | 5 | -44.44% |
30 Sep, 20 | 9 | 125.00% |
30 Jun, 20 | 4 | -42.86% |
31 Mar, 20 | 7 | - |
31 Mar, 12 | 1 | - |
17 institutional shareholders have increased their position in ANVS stock as of 30 Jun 24 compared to 29 in the previous quarter (a -41.38% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 14 | 133.33% |
31 Mar, 24 | 6 | -14.29% |
31 Dec, 23 | 7 | -12.50% |
30 Sep, 23 | 8 | 100.00% |
30 Jun, 23 | 4 | - |
31 Mar, 23 | 4 | -20.00% |
31 Dec, 22 | 5 | - |
30 Sep, 22 | 5 | -37.50% |
30 Jun, 22 | 8 | 14.29% |
31 Mar, 22 | 7 | -22.22% |
31 Dec, 21 | 9 | -10.00% |
30 Sep, 21 | 10 | -16.67% |
30 Jun, 21 | 12 | 71.43% |
31 Mar, 21 | 7 | 133.33% |
31 Dec, 20 | 3 | 200.00% |
30 Sep, 20 | 1 | - |
30 Jun, 20 | 1 | - |
31 Mar, 20 | - | - |
31 Mar, 12 | - | - |
14 institutional shareholders have reduced their position in ANVS stock as of 30 Jun 24 compared to 6 in the previous quarter (a 133.33% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 49 | -3.92% | 984,303 | -19.54% | 9.26% | 6.99% | 17 | -41.38% | 14 | 133.33% |
31 Mar, 24 | 51 | 15.91% | 1,223,331 | 1.56% | 11.51% | 7.20% | 29 | 16.00% | 6 | -14.29% |
31 Dec, 23 | 44 | 51.72% | 1,204,492 | 8.33% | 12.64% | 8.31% | 25 | 177.78% | 7 | -12.50% |
30 Sep, 23 | 29 | 3.57% | 1,111,900 | -13.05% | 12.34% | 6.05% | 9 | -25.00% | 8 | 100.00% |
30 Jun, 23 | 28 | 27.27% | 1,278,741 | 70.00% | 14.29% | 16.96% | 12 | 9.09% | 4 | - |
31 Mar, 23 | 22 | - | 752,202 | 1.52% | 9.18% | 11.14% | 11 | 37.50% | 4 | -20.00% |
31 Dec, 22 | 22 | - | 740,907 | 0.43% | 9.08% | 11.11% | 8 | - | 5 | - |
30 Sep, 22 | 22 | -8.33% | 737,704 | -4.25% | 9.04% | 10.15% | 8 | - | 5 | -37.50% |
30 Jun, 22 | 24 | 4.35% | 770,423 | -13.39% | 9.44% | 7.94% | 8 | -20.00% | 8 | 14.29% |
31 Mar, 22 | 23 | -20.69% | 889,559 | -20.29% | 10.90% | 5.09% | 10 | -23.08% | 7 | -22.22% |
31 Dec, 21 | 29 | -19.44% | 1,116,019 | -2.16% | 14.63% | 7.38% | 13 | -38.10% | 9 | -10.00% |
30 Sep, 21 | 36 | -35.71% | 1,140,634 | -10.12% | 14.08% | 4.75% | 21 | -50.00% | 10 | -16.67% |
30 Jun, 21 | 56 | 86.67% | 1,269,043 | 52.09% | 17.23% | 11.85% | 42 | 100.00% | 12 | 71.43% |
31 Mar, 21 | 30 | 150.00% | 834,414 | 9.80% | 12.06% | 8.31% | 21 | 320.00% | 7 | 133.33% |
31 Dec, 20 | 12 | 9.09% | 759,911 | 140.82% | 12.04% | 57.12% | 5 | -44.44% | 3 | 200.00% |
30 Sep, 20 | 11 | 37.50% | 315,551 | 29.41% | 4.59% | 36.36% | 9 | 125.00% | 1 | - |
30 Jun, 20 | 8 | 14.29% | 243,843 | 26.22% | 3.55% | 20.15% | 4 | -42.86% | 1 | - |
31 Mar, 20 | 7 | - | 193,186 | - | 4.20% | - | 7 | - | - | - |
31 Mar, 12 | 1 | - | 17,411 | - | 0.40% | - | 1 | - | - | - |
Annovis Bio Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Annovis Bio's stock was made by Maccecchini Maria-Luisa on Jul 03 2024, selling 10,000 shares at - per share (valued at -).
Annovis Bio Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 1 | - | - |
Q1 2024 | - | 3 | - |
Q4 2023 | 19 | - | - |
Q2 2023 | 6 | 1 | 600.00% |
Q1 2023 | 7 | 1 | 700.00% |
Q3 2022 | 1 | - | - |
Q1 2022 | 10 | 5 | 200.00% |
Q4 2021 | 7 | - | - |
Q3 2021 | 7 | - | - |
Q2 2021 | - | 1 | - |
Q3 2020 | 4 | - | - |
Q2 2020 | 2 | - | - |
Q1 2020 | 20 | 36 | 55.56% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Annovis Bio's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q3 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 3 | - | - |
Q3 2021 | 1 | - | - |
Q2 2021 | - | - | - |
Q3 2020 | - | - | - |
Q2 2020 | - | - | - |
Q1 2020 | 8 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Annovis Bio's stocks.
Annovis Bio Peer Ownership
Ticker | Company |
---|---|
GRCL | Gracell Biotechnologies Inc. |
CUE | Cue Biopharma, Inc. |
AVXL | Anavex Life Sciences Corp. |
IOVA | Iovance Biotherapeutics, Inc. |
RVPH | Reviva Pharmaceuticals Holdings, Inc. |
DAWN | Day One Biopharmaceuticals, Inc. |
MCRB | Seres Therapeutics, Inc. |
TERN | Terns Pharmaceuticals, Inc. |
INZY | Inozyme Pharma, Inc. |
AXSM | Axsome Therapeutics, Inc. |
LTRN | Lantern Pharma Inc. |
ABOS | Acumen Pharmaceuticals, Inc. |
TFFP | TFF Pharmaceuticals, Inc. |
INAB | IN8bio, Inc. |
SAVA | Cassava Sciences, Inc. |
NVAX | Novavax, Inc. |
ANIX | Anixa Biosciences, Inc. |
IMNM | Immunome, Inc. |
GRTX | Galera Therapeutics, Inc. |
ANVS Ownership FAQ
Who Owns Annovis Bio?
Annovis Bio is owned by institutional shareholders (9.26%), insiders (21.56%), and public (69.17%). The largest institutional shareholder of Annovis Bio is LMR PARTNERS LLP (5.38% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.01% of total shares).
Who are the major institutional shareholders of Annovis Bio?
Annovis Bio's major institutional shareholders are LMR PARTNERS LLP, VANGUARD GROUP INC, BOOTHBAY FUND MANAGEMENT, LLC, ALTIUM CAPITAL MANAGEMENT LP, and CAPTION MANAGEMENT, LLC. The top five shareholders own together 12.93% of the company's share outstanding.
How many Annovis Bio shareholders are there?
As of Jun 2024, there are 49 institutional shareholders of Annovis Bio.
What percentage of Annovis Bio is owned by LMR PARTNERS LLP?
LMR PARTNERS LLP owns 572.1K shares of Annovis Bio, representing 5.38% of the company's total shares outstanding, valued at $3.3M (as of Jun 2024).
What percentage of Annovis Bio is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 361.35K shares of Annovis Bio (ANVS), compromising 3.40% of the company, valued at $2.08M.
What percentage of Annovis Bio is owned by BOOTHBAY FUND MANAGEMENT, LLC?
BOOTHBAY FUND MANAGEMENT, LLC is the third largest holder of Annovis Bio. The company owns 160.3K of the company's shares outstanding (worth $923.33K).